| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000039318 |
| Receipt No. | R000044846 |
| Scientific Title | A verification test of psychological and physiological effects of aroma or intake of coffee. |
| Date of disclosure of the study information | 2020/08/31 |
| Last modified on | 2020/10/09 (Ver. 3) |
| Basic information | ||
| Public title | A verification test of psychological and physiological effects of aroma or intake of coffee. | |
| Acronym | A verification test of psychological and physiological effects of aroma or intake of coffee. | |
| Scientific Title | A verification test of psychological and physiological effects of aroma or intake of coffee. | |
| Scientific Title:Acronym | A verification test of psychological and physiological effects of aroma or intake of coffee. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To verify psychological and physiological effect of coffee aroma, and psychological and physiological change by intake coffee. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | *Evaluation of autonomic nervous system, by iris measurement, skin temperature measurement and heart rate change
* Evaluation of parasympathetic nervous system, by measurement for function of field of view and stabilometry *Flicker test |
| Key secondary outcomes | *POMS2 short version
*VAS questionnaire |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Resting more than 10min- measurements and questionnaires- suctioning coffee aroma- measurements and questionnaires- intake coffee- resting- measurements and questionnaires- resting- measurements and questionnaires | |
| Interventions/Control_2 | Resting more than 10min- measurements and questionnaires- suctioning water aroma- measurements and questionnaires- intake water- resting- measurements and questionnaires- resting- measurements and questionnaires | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Males and female who are students of NIHON UNIVERSITY aged more than 20 years when informed consent.
2. Subjects who are able to intake coffee. 3. Subjects who show understanding of the clinical study procedures and agreement with participating the study by written informed consent prior to the study. |
|||
| Key exclusion criteria | 1.Subjects who don't good at coffee aroma
2. Subjects who have smoking habit. 3. Subjects who are cold-sensitive constitution. (including subjects like that who feel cold on their hands and foots even in summer) 4. Subjects who are receiving medication due to treatment of disease. 5. In a past month, subjects who have had custom of taking or applying medicine for the treatment of diseases. (Except for cold but include for pollen allergy.) 6. Subjects who have stuffy nose such as allergic rhinitis, or subjects who are not able to determine aroma. 7. Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood. 8. Pregnant or expected pregnant, or lactating women. 9. Subjects who have symptom of dermatologic disease such as atopic dermatitis. 10. Subjects who feel pain in their knee, or subjects who feel pain or discomfort when bent their knee. 11. Subjects who have undergone surgery on investigation objective portion within the past 6 months. 12. Subjects who are participating the other clinical tests. Subjects who participated within a month prior to the current study and/or who plan to participate the other clinical tests. 13. Other who is determined ineligible by investigator. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | NIHON UNIVERSITY | ||||||
| Division name | College of Bioresource Science | ||||||
| Zip code | 252-0880 | ||||||
| Address | 1866 Kameino, Fujisawa-shi, Kanagawa 252-0880 Japan | ||||||
| TEL | 0466-84-3987 | ||||||
| Oohata.motoko@mihon-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | University of Tsukuba, School of Integrative | ||||||
| Division name | Global Majors | ||||||
| Zip code | 305-8577 | ||||||
| Address | 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577 Japan | ||||||
| TEL | 029-853-7344 | ||||||
| Homepage URL | |||||||
| yada.yukihiro.gb@u.tsukuba.ac.jp | |||||||
| Sponsor | |
| Institute | NIHON UNIVERSITY |
| Institute | |
| Department | |
| Funding Source | |
| Organization | NIHON UNIVERSITY |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | University of Tsukuba, School of Integrative |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board of Chiyoda Paramedical Care Clinic |
| Address | 2F Chushin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, Japan |
| Tel | 03-5297-5548 |
| IRB@cpcc.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 20 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044846 |